furosemide has been researched along with Amyloidosis in 11 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
Amyloidosis: A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The data on protein excretion with urine under the effect of furosemide were compared clinically and morphologically with the morphological signs of tubulostromal lesions in the kidneys in 19 patients suffering from amyloid nephropathy and in 33 patients with chronic glomerulonephritis." | 7.67 | [Effect of furosemide on proteinuria in patients suffering from amyloidosis and chronic nephritis with various tubulostromal lesions of the kidneys]. ( Pankrat'ev, LM; Varshavskiĭ, VA, 1989) |
| "The data on protein excretion with urine under the effect of furosemide were compared clinically and morphologically with the morphological signs of tubulostromal lesions in the kidneys in 19 patients suffering from amyloid nephropathy and in 33 patients with chronic glomerulonephritis." | 3.67 | [Effect of furosemide on proteinuria in patients suffering from amyloidosis and chronic nephritis with various tubulostromal lesions of the kidneys]. ( Pankrat'ev, LM; Varshavskiĭ, VA, 1989) |
| "All these findings indicated restrictive cardiomyopathy as part of primary systemic amyloidosis." | 1.29 | [Primary systemic amyloidosis with cardiac manifestations]. ( Fischer, H; Morell, R; Woitinas, F; Zwehl, W, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (45.45) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wada, Y | 1 |
| Kobayashi, D | 1 |
| Murakami, S | 1 |
| Oda, M | 1 |
| Hanawa, H | 1 |
| Kuroda, T | 1 |
| Nakano, M | 1 |
| Narita, I | 1 |
| Hoyer, RJ | 1 |
| Leung, N | 1 |
| Witzig, TE | 1 |
| Lacy, MQ | 1 |
| Cody, RJ | 1 |
| Fischer, H | 1 |
| Woitinas, F | 1 |
| Morell, R | 1 |
| Zwehl, W | 1 |
| Duda, SH | 1 |
| Raible, RT | 1 |
| Risler, T | 1 |
| Huppert, PE | 1 |
| Brambs, HJ | 1 |
| Gregor, M | 1 |
| Petzsch, M | 1 |
| Pulya, K | 1 |
| Anders, O | 1 |
| Geller, JC | 1 |
| Barkow, UH | 1 |
| Becher, H | 1 |
| Zhou, H | 1 |
| Vetter, H | 1 |
| Glänzer, K | 1 |
| Pankrat'ev, LM | 1 |
| Varshavskiĭ, VA | 1 |
| Muth, RG | 1 |
| Maldonado, JE | 1 |
| McNutt, DR | 1 |
| Kyle, RA | 1 |
| Baggenstoss, AH | 1 |
| Fudenberg, HH | 1 |
| Steinitz, L | 1 |
| Schreiter, G | 1 |
11 other studies available for furosemide and Amyloidosis
| Article | Year |
|---|---|
Cardiac AA amyloidosis in a patient with rheumatoid arthritis and systemic sclerosis: the therapeutic potential of biological reagents.
Topics: Aged; Amyloidosis; Antibodies, Antinuclear; Antirheumatic Agents; Arthritis, Rheumatoid; Benzimidazo | 2011 |
Treatment of diuretic refractory pleural effusions with bevacizumab in four patients with primary systemic amyloidosis.
Topics: Amyloidosis; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Captopril; Ches | 2007 |
Edema and heart failure without cardiomegaly.
Topics: Amyloidosis; Cardiomyopathies; Diuresis; Echocardiography; Edema; Foot; Furosemide; Hemodynamics; Hu | 1982 |
[Primary systemic amyloidosis with cardiac manifestations].
Topics: Aged; Amyloidosis; Cardiomyopathy, Restrictive; Dyspnea; Echocardiography; Electrocardiography; Fema | 1995 |
[Therapeutic bilateral renal artery embolization in the nephrotic syndrome].
Topics: Amyloidosis; Captopril; Cardiomyopathies; Contraindications; Creatinine; Crohn Disease; Drug Therapy | 1994 |
[Augmentation of left ventricular outflow tract gradient by digitalis glycosides in a case of cardiac (AL-) amyloidosis].
Topics: Amyloidosis; Asthma, Exercise-Induced; Cardiotonic Agents; Digitoxin; Diuretics; Echocardiography, D | 2001 |
[Restrictive cardiomyopathy caused by cardiac amyloidosis in multiple myeloma].
Topics: Aged; Amyloidosis; Biopsy; Captopril; Cardiomyopathy, Restrictive; Diagnosis, Differential; Digitoxi | 1992 |
[Effect of furosemide on proteinuria in patients suffering from amyloidosis and chronic nephritis with various tubulostromal lesions of the kidneys].
Topics: Amyloidosis; Chronic Disease; Furosemide; Glomerulonephritis; Humans; Kidney; Nephritis; Nephrotic S | 1989 |
Diuretic properties of furosemide in renal disease.
Topics: Acid-Base Equilibrium; Adolescent; Adult; Aged; Amyloidosis; Blood Urea Nitrogen; Creatine; Diabetic | 1968 |
IgG cryoglobulinemia associated with amyloidosis.
Topics: Amyloidosis; Autoantibodies; Blood Protein Disorders; Bone Marrow Examination; Chlorambucil; Cryoglo | 1973 |
[Amyloidosis in childhood].
Topics: Amyloidosis; Child; Chronic Disease; Encephalomyelitis; Furosemide; Humans; Male; Nephrotic Syndrome | 1971 |